Johnson Matthey appoints Linda Bruce-Watt as Interim Company Secretary

Pharma

Following the retirement and resignation of Simon Farrant as Company Secretary on 31st March 2020, the Board of Directors of Johnson Matthey Plc (LON:JMAT) has approved the appointment of Linda Bruce-Watt as Interim Company Secretary with effect from 1st April 2020.

Johnson Matthey is a British multinational speciality chemicals and sustainable technologies company headquartered in the United Kingdom. It is listed on the London Stock Exchange and is a constituent of the FTSE 100 Index

Share on:

Latest Company News

Johnson Matthey issues pre-close update and reclassifies Catalyst Technologies

Johnson Matthey has confirmed that Catalyst Technologies, following its agreed sale to Honeywell, will be reported as a discontinued operation for 2025/26. In its pre-close update for the half year to 30 September 2025, the group expects strong growth in underlying operating profit, supported by efficiency gains and robust trading in PGM Services.

Johnson Matthey appoints Richard Pike as Chief Financial Officer Designate

Johnson Matthey plc appoints Richard Pike as Chief Financial Officer Designate, effective immediately, ensuring a smooth transition before April 2025.

Johnson Matthey Plc hosting PGM Services seminar for investors and analysts today

Join Johnson Matthey plc (LON:JMAT) as they host a PGM Services seminar, revealing how PGM Services drive the net zero transition and unlock growth opportunities.

Johnson Matthey Plc to sell Medical Device Components business for $700 million

Johnson Matthey Plc (LON:JMAT) has signed an agreement to sell its Medical Device Components business to Montagu Private Equity for US$700 million (£550 million).

    Search

    Search